GL1X · GenesisL1 explorer

MolNFT v2 · #7263 · protein

1G1E: NMR structure of the human MAD1 transrepression domain sid in complex with mammalian SIN3A PAH2 domain

1G1E · MAD1 protein: “NMR structure of the human MAD1 transrepression domain sid in complex with mammalian SIN3A PAH2 domain”. Solution nmr at NOT. MolNFT v2 #7263 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

3D structure of 1G1E: NMR structure of the human MAD1 transrepression domain sid in complex with mammalian SIN3A PAH2 domain (MolNFT v2 / PDB Bank)
3D structure of 1G1E: NMR structure of the human MAD1 transrepression domain sid in complex with mammalian SIN3A PAH2 domain (MolNFT v2 / PDB Bank)
PDB
1G1E
Type
protein
Length
105 residues
Chains
2
Method
solution nmr
Authors
Brubaker, K., Cowley, S.M., Huang, K., Eisenman, R.N., Radhakrishnan, I.
Deposited
10/11/00
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
NOT
Source
Mus musculus; SYNTHETIC CONSTRUCT
Molecule
MAD1 protein; SIN3A
UniProt
Q60520

Structure

solution nmr · resolution NOT · 2 distinct chains · 68% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMAD1 proteinprotein1681% helix, 0% strand—
BSIN3Aprotein8965% helix, 0% strandQ60520

Interfaces

1 interface between chains.

  • A–B · 804 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 1G1E · NMR structure of the human MAD1 transrepression domain sid in complex with mammalian… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q60520 · AlphaFold monomer V2.0 prediction for paired amphipathic helix protein SIN3A (Q60520) · a predicted model of the same protein · chain B against A, TM-score 0.79

Analyse

Other records of 1G1E

  • 1G1E-2 · MolNFT v1 / PDB · NMR structure of the human MAD1 transrepression domain sid in complex with mammalian…

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.